Cortexyme Secures $7,918,642 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c925d377-1473-49aa-8a5c-4b539c009853 - Date
1/5/2016 - Company Name
Cortexyme - Mailing Address
329 Oyster Point South San Francisco, CA 94080 USA - Company Description
Cortexyme is developing novel treatments for altering the course of Alzheimer’s and other neurological diseases. - Website
http://www.cortexyme.com - Transaction Type
Venture Equity - Transaction Amount
$7,918,642 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 13 investors participated in the offering. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
